AIMS: To investigate the effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency in early-stage hypertension. METHODS AND RESULTS: We studied 527 participants from two clinical trials assessing the effect of blood pressure lowering on diastolic function. Participants were aged ≥45 years with early-stage hypertension, no heart failure, ejection fraction (EF) ≥50%, and diastolic dysfunction using Doppler echocardiography. Effective arterial afterload and its components were assessed along with measures of left ventricular (LV) structure and function prior to and after 24-38 weeks of antihypertensive therapy. Systolic blood pressure decreased from 154 ± 18 to 137 ± 15 mmHg at follow-up. Blood pressure reduction was associated with decreases in ventricular and arterial stiffness, improvements in systemic arterial compliance and resistance, enhanced LV ejection, and reduction in cardiac work (all P < 0.001). Changes in Ea/Ees ratio were inversely correlated with those in EF (r = -0.25; P < 0.001), stroke work index (r = -0.13; P = 0.007), and LV efficiency (r = -0.98; P < 0.001); and directly related to changes in mitral E/e' (r = 0.12; P = 0.01). Adjusting for age and blood pressure change, women and obese individuals had less enhancement in ventricular-arterial coupling and efficiency compared with men and non-obese individuals (P = 0.04 and 0.007, respectively). CONCLUSION: Antihypertensive therapy reduces arterial and ventricular stiffness, enhances ventricular-arterial coupling, reduces cardiac work, and improves LV efficiency, systolic, and diastolic function. Attenuated responses in women and among obese subjects suggest that structure-function changes may be less reversible in these groups, possibly explaining their greater susceptibility to ultimately develop heart failure.
AIMS: To investigate the effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency in early-stage hypertension. METHODS AND RESULTS: We studied 527 participants from two clinical trials assessing the effect of blood pressure lowering on diastolic function. Participants were aged ≥45 years with early-stage hypertension, no heart failure, ejection fraction (EF) ≥50%, and diastolic dysfunction using Doppler echocardiography. Effective arterial afterload and its components were assessed along with measures of left ventricular (LV) structure and function prior to and after 24-38 weeks of antihypertensive therapy. Systolic blood pressure decreased from 154 ± 18 to 137 ± 15 mmHg at follow-up. Blood pressure reduction was associated with decreases in ventricular and arterial stiffness, improvements in systemic arterial compliance and resistance, enhanced LV ejection, and reduction in cardiac work (all P < 0.001). Changes in Ea/Ees ratio were inversely correlated with those in EF (r = -0.25; P < 0.001), stroke work index (r = -0.13; P = 0.007), and LV efficiency (r = -0.98; P < 0.001); and directly related to changes in mitral E/e' (r = 0.12; P = 0.01). Adjusting for age and blood pressure change, women and obese individuals had less enhancement in ventricular-arterial coupling and efficiency compared with men and non-obese individuals (P = 0.04 and 0.007, respectively). CONCLUSION: Antihypertensive therapy reduces arterial and ventricular stiffness, enhances ventricular-arterial coupling, reduces cardiac work, and improves LV efficiency, systolic, and diastolic function. Attenuated responses in women and among obese subjects suggest that structure-function changes may be less reversible in these groups, possibly explaining their greater susceptibility to ultimately develop heart failure.
Authors: Scott L Hummel; E Mitchell Seymour; Robert D Brook; Samar S Sheth; Erina Ghosh; Simeng Zhu; Alan B Weder; Sándor J Kovács; Theodore J Kolias Journal: Circ Heart Fail Date: 2013-08-28 Impact factor: 8.790
Authors: Jason V Tso; Casey G Turner; Chang Liu; Syed Ahmad; Abbas Ali; Steve Selvaraj; Angelo Galante; Carla R Gilson; Craig Clark; B Robinson Williams; Arshed A Quyyumi; Aaron L Baggish; Jonathan H Kim Journal: J Am Heart Assoc Date: 2022-02-24 Impact factor: 6.106
Authors: Andreas Rolf; Johannes Rixe; Won K Kim; Johannes Börgel; Helge Möllmann; Holger M Nef; Christoph Liebetrau; Thorsten Kramm; Stefan Guth; Gabriele A Krombach; Eckhard Mayer; Christian W Hamm Journal: J Cardiovasc Magn Reson Date: 2014-12-05 Impact factor: 5.364
Authors: Francesco Antonini-Canterin; Stefano Poli; Olga Vriz; Daniela Pavan; Vitantonio Di Bello; Gian Luigi Nicolosi Journal: J Cardiovasc Echogr Date: 2013 Oct-Dec
Authors: Senthil Selvaraj; Brian L Claggett; Michael Böhm; Stefan D Anker; Muthiah Vaduganathan; Faiez Zannad; Burkert Pieske; Carolyn S P Lam; Inder S Anand; Victor C Shi; Martin P Lefkowitz; John J V McMurray; Scott D Solomon Journal: J Am Coll Cardiol Date: 2020-03-16 Impact factor: 24.094